Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Roland Lescure at the Future4Care Incubator for the French Tech - Paris AJ

Group photo with CEO of Future4Care, Agnes De Leersnyder, Orange Head of Group Strategy, Jerome Berger, Orange CEO, Christel Heydemann, French Minister of the Economy, Finance and Industrial, Energy and Digital Sovereignty Roland Lescure, Director French Tech Mission, Julie Huguet, French Deputy Minister for Artificial Intelligence and Digital Anne Le Henanff, CEO co-founder WhiteLab Genomics, David Del Bourgo and CEO of Biolevate, Joel Belafa during a visit by government ministers to the Future4Care (Future 4 care) incubator in Paris, France, on November 6, 2025, for the announcement of the 2025 cohort of the French Tech 2030 program, the French Tech Mission, through its support of startups shaping the technologies of tomorrow and strengthening France's digital sovereignty in strategic areas such as artificial intelligence (AI / IA), cybersecurity, robotics, quantum computing, and semiconductors, revealed the winning companies alongside the CEO of Orange, sponsor of this new cohort, and the director of the F

E

Roland Lescure at the Future4Care Incubator for the French Tech - Paris AJ

Group photo with CEO of Future4Care, Agnes De Leersnyder, Orange Head of Group Strategy, Jerome Berger, Orange CEO, Christel Heydemann, French Minister of the Economy, Finance and Industrial, Energy and Digital Sovereignty Roland Lescure, Director French Tech Mission, Julie Huguet, French Deputy Minister for Artificial Intelligence and Digital Anne Le Henanff, CEO co-founder WhiteLab Genomics, David Del Bourgo and CEO of Biolevate, Joel Belafa during a visit by government ministers to the Future4Care (Future 4 care) incubator in Paris, France, on November 6, 2025, for the announcement of the 2025 cohort of the French Tech 2030 program, the French Tech Mission, through its support of startups shaping the technologies of tomorrow and strengthening France's digital sovereignty in strategic areas such as artificial intelligence (AI / IA), cybersecurity, robotics, quantum computing, and semiconductors, revealed the winning companies alongside the CEO of Orange, sponsor of this new cohort, and the director of the F

E

Roland Lescure at the Future4Care Incubator for the French Tech - Paris AJ

Group photo with CEO of Future4Care, Agnes De Leersnyder, Orange Head of Group Strategy, Jerome Berger, Orange CEO, Christel Heydemann, French Minister of the Economy, Finance and Industrial, Energy and Digital Sovereignty Roland Lescure, Director French Tech Mission, Julie Huguet, French Deputy Minister for Artificial Intelligence and Digital Anne Le Henanff, CEO co-founder WhiteLab Genomics, David Del Bourgo and CEO of Biolevate, Joel Belafa during a visit by government ministers to the Future4Care (Future 4 care) incubator in Paris, France, on November 6, 2025, for the announcement of the 2025 cohort of the French Tech 2030 program, the French Tech Mission, through its support of startups shaping the technologies of tomorrow and strengthening France's digital sovereignty in strategic areas such as artificial intelligence (AI / IA), cybersecurity, robotics, quantum computing, and semiconductors, revealed the winning companies alongside the CEO of Orange, sponsor of this new cohort, and the director of the F

E

Roland Lescure at the Future4Care Incubator for the French Tech - Paris AJ

Group photo with CEO of Future4Care, Agnes De Leersnyder, Orange Head of Group Strategy, Jerome Berger, Orange CEO, Christel Heydemann, French Minister of the Economy, Finance and Industrial, Energy and Digital Sovereignty Roland Lescure, Director French Tech Mission, Julie Huguet, French Deputy Minister for Artificial Intelligence and Digital Anne Le Henanff, CEO co-founder WhiteLab Genomics, David Del Bourgo and CEO of Biolevate, Joel Belafa during a visit by government ministers to the Future4Care (Future 4 care) incubator in Paris, France, on November 6, 2025, for the announcement of the 2025 cohort of the French Tech 2030 program, the French Tech Mission, through its support of startups shaping the technologies of tomorrow and strengthening France's digital sovereignty in strategic areas such as artificial intelligence (AI / IA), cybersecurity, robotics, quantum computing, and semiconductors, revealed the winning companies alongside the CEO of Orange, sponsor of this new cohort, and the director of the F

E

Roland Lescure at the Future4Care Incubator for the French Tech - Paris AJ

Group photo with CEO of Future4Care, Agnes De Leersnyder, Orange Head of Group Strategy, Jerome Berger, Orange CEO, Christel Heydemann, French Minister of the Economy, Finance and Industrial, Energy and Digital Sovereignty Roland Lescure, Director French Tech Mission, Julie Huguet, French Deputy Minister for Artificial Intelligence and Digital Anne Le Henanff, CEO co-founder WhiteLab Genomics, David Del Bourgo and CEO of Biolevate, Joel Belafa during a visit by government ministers to the Future4Care (Future 4 care) incubator in Paris, France, on November 6, 2025, for the announcement of the 2025 cohort of the French Tech 2030 program, the French Tech Mission, through its support of startups shaping the technologies of tomorrow and strengthening France's digital sovereignty in strategic areas such as artificial intelligence (AI / IA), cybersecurity, robotics, quantum computing, and semiconductors, revealed the winning companies alongside the CEO of Orange, sponsor of this new cohort, and the director of the F

E

Business Day - Summit for action on AI in Paris - FA

CEO et cofondateur of WhiteLab Genomics David Del Bourgo looks on during Business Day - Summit for action on artificial intelligence at Station F in Paris on February 11, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Business Day - Summit for action on AI in Paris - FA

CEO et cofondateur of WhiteLab Genomics David Del Bourgo looks on during Business Day - Summit for action on artificial intelligence at Station F in Paris on February 11, 2025. Photo by Firas Abdullah/ABACAPRESS.COM

E

Global Digital Trade Expo in Hangzhou

HANGZHOU, CHINA - SEPTEMBER 25, 2024 - Viewers watch BGI Genomics' ultra-high throughput sequencer at the Global Digital Trade Expo on September 25, 2024, in Hangzhou, Zhejiang Province, China.

E

CHINA-GUANGDONG-RESEARCH-INSECT OLFACTORY MECHANISM-GREEN PESTICIDES (CN)

(240615) -- BEIJING, June 15, 2024 Photo by Xinhua/ABACAPRESS.COM) -- This file photo taken on Dec. 13, 2023 shows Wang Guirong observing insects at the Agricultural Genomics Institute at Shenzhen under the Chinese Academy of Agricultural Sciences (CAAS) in Shenzhen, south China's Guangdong Province. TO GO WITH "Chinese scientists reveal insect olfactory mechanism to help develop green pesticides" (CAAS/Handout via Xinhua/ABACAPRESS.COM

E

Chinese genomics firm, Rwanda launch cervical cancer screening activities

STORY: Chinese genomics firm, Rwanda launch cervical cancer screening activities SHOOTING TIME: April 30, 2024 DATELINE: May 2, 2024 LENGTH: 00:03:42 LOCATION: Kigali CATEGORY: MEDICINE SHOTLIST: 1. various of the Remera health center 2. various of the Rwanda biomedical center 3. SOUNDBITE 1 (English): ALBERT TUYISHIME, Head of Department of HIV/AIDS Disease Prevention and Control at Rwanda Biomedical Center 4. SOUNDBITE 2 (Chinese): DU YUTAO, Chief operating officer of BGI Genomics STORYLINE: The Genomics Institute-BGI Genomics, the world's leading integrated solutions provider of precision medicine, in cooperation with the Rwanda Biomedical Center (RBC), launched a cervical cancer screening program on Tuesday at Remera Health Center in the Ngoma District of Eastern Province. The cancer screening activities will provide 20,000 human papillomavirus (HPV) DNA tests for local women, aiming to enhance cervical cancer screening and prevention efforts and improve local precision medical testing capabilities.

E

RWANDA-KIGALI-HPV-SCREENING

(240501) -- KIGALI, May 1, 2024 (Xinhua) -- A health worker explains cervical cancer testing and prevention at Remera Health Center in the Remera sector, Ngoma district, Eastern Province, Rwanda on April 30, 2024. The Genomics Institute-BGI Genomics, the world's leading integrated solutions provider of precision medicine, in cooperation with the Rwanda Biomedical Center, launched a cervical cancer screening program on Tuesday at Remera Health Center. (Xinhua/Ji Li)

E

RWANDA-KIGALI-HPV-SCREENING

(240501) -- KIGALI, May 1, 2024 (Xinhua) -- A health worker explains cervical cancer testing and prevention at Remera Health Center in the Remera sector, Ngoma district, Eastern Province, Rwanda on April 30, 2024. The Genomics Institute-BGI Genomics, the world's leading integrated solutions provider of precision medicine, in cooperation with the Rwanda Biomedical Center, launched a cervical cancer screening program on Tuesday at Remera Health Center. (Xinhua/Ji Li)

E

Officials, business leaders expect more China-Arab cooperation

STORY: Officials, business leaders expect more China-Arab cooperation DATELINE: June 13, 2023 LENGTH: 00:02:41 LOCATION: Cairo CATEGORY: POLITICS/ECONOMY SHOTLIST: 1. various of the conference 2. SOUNDBITE 1 (Arabic): AMIN SALAM, Lebanese Economy and Trade Minister 3. SOUNDBITE 2 (Arabic): BANDAR ALKHORAYEF, Saudi Minister of Industry and Mineral Resources 4. SOUNDBITE 3 (Chinese): YIN YE, CEO of BGI Genomics Co., Ltd. 5. SOUNDBITE 4 (Arabic): MESHARI ALDAKHIL, CEO & Co-Founder of GFS Express 6. various of the conference STORYLINE: Officials and business leaders have expressed expectations of more trade and cooperation between the Arab countries and China at the 10th Arab-China Business Conference. Kicked off in the Saudi capital of Riyadh on Sunday, the two-day conference brought together more than 3,000 representatives from over 20 countries and regions. SOUNDBITE 1 (Arabic): AMIN SALAM, Lebanese Economy and Trade Minister "Lebanon has strong relations with China. We believe the relationship between Sa

E

Omicron variant XBB.3 feared to be dominant in India in a month: report

STORY: Omicron variant XBB.3 feared to be dominant in India in a month: report DATELINE: Oct. 26, 2022 LENGTH: 00:01:30 LOCATION: New Delhi CATEGORY: HEALTH SHOTLIST: 1. various of India gate 2. various of crowded market areas 3. various of people receiving COVID-19 testing 4. various of the hospital area 5. various of street views STORYLINE: The Omicron sub-variant XBB, particularly XBB.3, is likely to be the dominant strain of the COVID-19 virus in India within a month, reported The Times of India newspaper on Tuesday citing scientists. According to the report, there were 71 confirmed cases of XBB-driven COVID-19 infection in India at the beginning of this month, and the number jumped to 136 by Oct. 23. "On Monday the case count was 235," it added. It quoted a senior scientist with the Indian SARS-CoV-2 Genomics Consortium (INSACOG) as saying that the XBB.3 strain is currently leading the pack in India "with maximum cases." According to the report, the eastern state of West Bengal has reported the hig

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows a biological laboratory engineer working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows samples for COVID-19 tests in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows BGI Health Ethiopia PLC Administration Director Saron Tamirat speaking during an interview at the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows Eyuel Fikru, a local team coordinator at the inflatable COVID-19 testing lab Huo-Yan Air Lab, speaking during an interview at Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows Kominist Asmamaw, a biological laboratory engineer at BGI Health Ethiopia, working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

ETHIOPIA-ADDIS ABABA-CHINESE COMPANY-COVID-19 TESTING LAB

(220517) -- ADDIS ABABA, May 17, 2022 (Xinhua) -- Photo taken on May 4, 2022 shows Kominist Asmamaw, a biological laboratory engineer at BGI Health Ethiopia, working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) TO GO WITH Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

E

India reports 2nd case of Omicron XE variant of COVID-19

STORY: India reports 2nd case of Omicron XE variant of COVID-19 DATELINE: April 9, 2022 LENGTH: 00:01:33 LOCATION: New Delhi CATEGORY: HEALTH SHOTLIST: 1. various of New Delhi STORYLINE: India has reported its second case of Omicron XE variant of COVID-19, this time from its western state of Gujarat, a minister in the state government said on Saturday. The 67-year-old patient had tested positive for COVID-19 last month. His sample was sent to the Indian SARS-CoV-2 Genomics Consortium for further testing, with the report coming back confirming the presence of the new variant. The patient reportedly has a travel history from Mumbai city, where the country's first Omicron XE case was reported a couple of days ago. Xinhua News Agency correspondents reporting from New Delhi. (XHTV)

E

Xinhua Headlines: China expands COVID-19 test kits production to meet surging global needs

(220206) -- GUANGZHOU, Feb. 6, 2022 (Xinhua) -- A staff member (R) of BGI Genomics provides training for an Ethiopian employee at a COVID-19 test kits production plant in Ethiopia, in November, 2020. (Xinhua)